amikacin has been researched along with sulbactam in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (19.15) | 18.2507 |
| 2000's | 19 (40.43) | 29.6817 |
| 2010's | 16 (34.04) | 24.3611 |
| 2020's | 3 (6.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fulcher, LC; Griffith, ME; Hawley, JS; Hospenthal, DR; Jorgensen, JH; McElmeel, ML; Murray, CK | 1 |
| Hawley, JS; Jorgensen, JH; Murray, CK | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bauraing, C; Bogaerts, P; Cuzon, G; Deplano, A; Glupczynski, Y; Lissoir, B; Naas, T; Nordmann, P | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, FY; Chen, TL; Fung, CP; Huang, LY; Lu, PL; Siu, LK | 1 |
| Chang, FY; Chen, TL; Fung, CP; Hsueh, PR; Ko, WC; Kuo, SC; Lee, YT; Siu, LK | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Andry, G; Aoun, M; Chantrain, G; Daneau, D; Deraemaecker, R; Dor, P; Ewalenko, P; Meunier, F; Phan, M; Van der Auwera, P | 1 |
| Anderson, PH; Barry, AL; Fuchs, PC; Shilling, S; Stickel, S | 1 |
| Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
| Baron, D; Bugnon, D; Caillon, J; Drugeon, H; Le Conte, P; Le Floch, R; Le Gallou, F; Potel, G; Xiong, YQ; Zhou, XY | 1 |
| Hirose, S; Inoue, T; Ito, K; Mano, K; Mita, S; Morita, Y; Sukoh, M; Takahashi, T; Togano, Y; Yamanaka, K | 1 |
| Kawada, E; Maehara, T; Matsushima, T; Morita, K; Murayama, K; Okamoto, K; Sadakata, H; Sawamura, M; Tamura, J; Tamura, K | 1 |
| Fukuda, M; Hirashima, K | 1 |
| Hirakawa, K; Horiike, S; Kuzuyama, Y; Misawa, S; Nakai, H; Nishida, K; Seriu, T; Takashima, T; Tanaka, S; Tsuda, S | 1 |
| Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
| Bessho, M; Endo, K; Fukuda, M; Hirasima, K; Ito, K; Kawai, N; Tominaga, K | 1 |
| Chankova, D; Dinev, N; Savov, E; Vatcheva, R | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Elisaf, M; Liberopoulos, E; Pappas, G; Tsianos, E | 1 |
| Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
| Pang, XY; Tian, BW; Yang, YJ | 1 |
| Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
| Chang, CY; Chang, YL; Hsu, CK; Hsueh, PR; Kuo, LC; Lai, CC; Liao, CH | 1 |
| Corti, M; Metta, H; Palmieri, O; Schtirbu, R | 1 |
| Duttagupta, S; Kochhar, P; Sarkar, S; Suvarna, V | 1 |
| Chandra, A; Desai, C; Dhar, P; Dharap, S; Goel, A; Gupta, R; Hardikar, JV; Kapoor, VK; Kochhar, P; Mathur, AK; Modi, P; Narwaria, M; Ramesh, H; Ramesh, MK; Sastry, RA; Schou, M; Shah, S; Somasundaram, S; Sreevathsa, MR; Sudheer, OV; Varshney, S; Virk, S | 1 |
| Hsieh, FC; Lee, CM; Leung, CH; Liu, CP; Wang, NY; Weng, LC | 1 |
| Barrou, L; Benslama, A; Charra, B; Hachimi, A; Idali, B; Motaouakkil, S | 1 |
| Esposito, S; Farina, D; Gallo, E; Gastaldo, L; Manzoni, P; Principi, N | 1 |
| Dhanawade, SS; Kakade, GM; Shah, SD | 1 |
| Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V | 1 |
| Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
| Gao, L; Li, Y; Lyu, Y | 1 |
| Ali, I; Shabbir, M | 1 |
| Cai, Y; Wang, J; Wang, R; Yang, D | 1 |
| Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J | 1 |
| Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
| Hakamifard, A; Naji Esfahani, SS; Shafiee, F; Soltani, R | 1 |
| Cao, Y; Liu, C; Ren, H; Shang, Z; Wang, R; Xie, L; Yang, Y; Zhang, J | 1 |
| Acman, M; Chiu, CH; Hamawandi, A; Lindsay, JA; Readman, JB; Sharland, M; Standing, JF | 1 |
1 review(s) available for amikacin and sulbactam
| Article | Year |
|---|---|
Enterococcus casseliflavus bacteremia. Case report and literature review.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Infective Agents; Bacteremia; Coccidiosis; Drug Therapy, Combination; Enterococcus; Female; Humans; Sulbactam | 2004 |
9 trial(s) available for amikacin and sulbactam
| Article | Year |
|---|---|
Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Clindamycin; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Premedication; Prospective Studies; Sulbactam | 1992 |
[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sulbactam; Tobramycin | 1994 |
[Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Sulbactam | 1993 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2003 |
Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Topics: Abdomen; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Humans; India; Male; Metronidazole; Middle Aged; Sulbactam; Treatment Outcome | 2008 |
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Child; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Metronidazole; Middle Aged; Peritonitis; Sulbactam; Treatment Failure; Treatment Outcome | 2008 |
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam | 2013 |
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult | 2018 |
37 other study(ies) available for amikacin and sulbactam
| Article | Year |
|---|---|
Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Military Personnel; Minocycline; Polymyxin B; United States; Warfare | 2007 |
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genes, Bacterial; Humans | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Gene Transfer, Horizontal; Genes, Bacterial; Humans; In Vitro Techniques; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Taiwan | 2010 |
Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Molecular Sequence Data; Plasmids; Taiwan | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Interactions; Drug Therapy, Combination; Gentamicins; Immunoenzyme Techniques; Netilmicin; Piperacillin; Sulbactam; Tobramycin | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
Treatment of experimental rabbit infective endocarditis due to a multidrug-resistant Pseudomonas aeruginosa with high-dose ceftazidime alone and combined with amikacin or sulbactam or both.
Topics: Amikacin; Animals; Aortic Valve; beta-Lactamases; Ceftazidime; Drug Administration Schedule; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis; Female; Heart Valve Diseases; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sulbactam | 1995 |
[Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Sulbactam | 1993 |
[A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Leukocyte Count; Male; Middle Aged; Neutrophils; Sulbactam | 1993 |
[Clinical analysis of neutropenic fever associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents, Urinary; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Fever; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Serum Albumin; Sulbactam | 2001 |
In vitro investigation of the susceptibility of Acinetobacter baumannii strains isolated from clinical specimens to ampicillin/sulbactam alone and in combination with amikacin.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Sulbactam | 2002 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
[Dynamic analysis of drug resistance of Pseudomonas aeruginosa in laboratory and clinical two-drug regimen].
Topics: Amikacin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Tazobactam | 2005 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Treatment Outcome | 2007 |
[Acute phlegmonous gastritis in a patient with AIDS].
Topics: Abdomen, Acute; Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Anti-Bacterial Agents; Cellulitis; Drug Therapy, Combination; Duodenitis; Gastritis; Humans; Laparotomy; Linitis Plastica; Male; Melena; Stomach; Sulbactam; Ultrasonography | 2007 |
Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Bacteremia; Ceftazidime; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, Teaching; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sulbactam; Taiwan | 2008 |
Intrathecal use of amikacin: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Amikacin; Anti-Bacterial Agents; Craniotomy; Fatal Outcome; Humans; Injections, Spinal; Male; Meningitis, Bacterial; Subarachnoid Hemorrhage; Sulbactam | 2008 |
Switch therapy in full-term neonates with presumed or proven bacterial infection.
Topics: Administration, Oral; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Case-Control Studies; Cefpodoxime; Ceftizoxime; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infusions, Intravenous; Male; Sulbactam | 2009 |
Papillon-lefevre syndrome with liver abscess.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Child; Dermatologic Agents; Humans; Isotretinoin; Liver Abscess; Male; Papillon-Lefevre Disease; Periodontitis; Skin Diseases; Sulbactam | 2009 |
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam | 2011 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Luminescent Measurements; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Colistin; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Tazobactam; Urinary Calculi; Urinary Tract; Urinary Tract Infections | 2023 |
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Prevalence; Sulbactam | 2023 |